Dr. Jordan Cameron Tasse, MD

Dr. Tasse practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Dr. Tasse's NPI, 1750538260, was assigned on August 26, 2008. Dr. Tasse holds Illinois license 036126736.

Dr. Tasse's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Dr. Tasse's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. Dr. Tasse is also affiliated with Resurrection Medical Center. The medical group on file is Rush University Internists. Dmand AI also links Dr. Tasse to 4 more hospitals and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tasse practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Tasse's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Tasse is licensed in Illinois.

CMS data shows 727 Medicare services from Dr. Tasse across 23 procedure codes in 2024, for 423 Medicare patients. Medicare paid $34,497 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 423 Medicare patients who saw Dr. Tasse in 2024. The largest group is 65 to 74, with 186 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 3.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tasse's median patient age at 69, with 50% women.

In 2024, Dr. Tasse wrote 21 Medicare Part D claims for 14 patients. 76% of them were for generic drugs.

Dr. Tasse accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tasse as offering telehealth. CMS counts 74 procedures of removal of tissue by Dr. Tasse, more than 82% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Tasse, published from 2014 to 2025. 2025 was the busiest year, with 3. The most frequent topics are Liver Neoplasms, Embolization, Therapeutic and Portal Vein. Dr. Tasse has published most often in J Vasc Interv Radiol. Dr. Tasse's most frequent co-authors are Bulent Arslan, MD, Ulku C. Turba, MD and Sreekumar Madassery, MD.

Dmand AI links Dr. Tasse to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Arteriovenous Fistula, Arteriovenous Malformations and Postthrombotic Syndrome. Open Payments lists research payments to Dr. Tasse that name 1 trial.

CMS Open Payments shows 143 general payments to Dr. Tasse from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. C. R. Bard, Inc. & Subsidiaries paid the most, $14,413. It also lists 5 research payments totaling $3,469 in 2016, naming 1 clinical trial.